Related Experiment Video
Updated: Jul 20, 2025
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
9.6K
Recurrent Retroperitoneal Spindle Cell Sarcoma: A Challenging Case Report and Management Considerations
Raghu Halappa Nagaraj1, Han Grezenko2, Yogesh Raut3
1Surgery, Avalon University School of Medicine, Willemstad, CUW.
Cureus
|July 31, 2023
Summary
This case study discusses a rare retroperitoneal spindle cell sarcoma (RPSCS) in an elderly male. Despite surgical intervention and planned chemotherapy, the aggressive tumor recurred, resulting in a fatal outcome, underscoring diagnostic and therapeutic challenges.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Soft-tissue sarcomas (STS) are a diverse group of malignant mesenchymal tumors.
- Spindle cell sarcoma is a rare subtype presenting significant diagnostic and therapeutic challenges.
Observation:
- A case of an 80-year-old male with retroperitoneal spindle cell sarcoma (RPSCS) is presented.
- The patient underwent surgical tumor excision followed by planned adjuvant chemotherapy.
Findings:
- The RPSCS demonstrated aggressive recurrence post-surgery.
- The patient experienced a fatal outcome due to tumor progression.
Implications:
- This case emphasizes the rarity and aggressive nature of retroperitoneal spindle cell sarcoma.
- Accurate diagnosis, optimal surgical strategy, and effective adjuvant therapies are crucial for managing RPSCS.
